Manufacturing capacity for diagnostics increased at a rapid rate during the COVID-19 pandemic. It is estimated to have grown by 200% since the onset of the pandemic. Sustaining this expanded capacity over the long term will require coordinated strategies to ensure the progress made in recent years is not lost. 

The authors of this commentary piece, representing the ACT-A Diagnostics Partnership, suggest strategies which could be implemented to preserve manufacturing capacity in the face of future pandemic threats.